Matthias Lüke
- Ophthalmology top 0.5%
- Radiology, Nuclear Medicine and Imaging top 5%
- Molecular Biology
- Immunology
- Cellular and Molecular Neuroscience
- Co-authors
- Salvatore GrisantiJulia LükeKhaled NassarKarl Ulrich Bartz‐SchmidtToni SchneiderJulia BeutelSwaantje GrisantiChristoph Lüke
- Topics
- Retinal Diseases and Treatments (29 papers)Retinal Development and Disorders (22 papers)Retinal and Macular Surgery (17 papers)
- Partner nations
- GermanyEgyptNetherlands
In The Last Decade
Matthias Lüke
58 papers receiving 925 citations
Peers
Comparison fields: 5 of 65
- Ophthalmology 732
- Radiology, Nuclear Medicine and Imaging 416
- Molecular Biology 365
- Immunology 99
- Cellular and Molecular Neuroscience 94
Countries citing papers authored by Matthias Lüke
This map shows the geographic impact of Matthias Lüke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Lüke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Lüke more than expected).
Fields of papers citing papers by Matthias Lüke
This network shows the impact of papers produced by Matthias Lüke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Lüke. The network helps show where Matthias Lüke may publish in the future.
Co-authorship network of co-authors of Matthias Lüke
This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Lüke. A scholar is included among the top collaborators of Matthias Lüke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Lüke. Matthias Lüke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 8 | |
| 3 | 3 | |
| 4 | 3 | |
| 5 | 11 | |
| 6 | Inflammatory Cytokines in Age Related Macular Degeneration (AMD): Relationships to Disease Activity | 1 |
| 7 | 12 | |
| 8 | 5 | |
| 9 | 9 | |
| 10 | 38 | |
| 11 | 5 | |
| 12 | 12 | |
| 13 | 33 | |
| 14 | 26 | |
| 15 | 13 | |
| 16 | 12 | |
| 17 | 15 | |
| 18 | 3 | |
| 19 | 16 | |
| 20 | 7 |
About Matthias Lüke
Matthias Lüke is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Cellular and Molecular Neuroscience, having authored 58 papers that have together received 948 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (29 papers), Retinal Development and Disorders (22 papers) and Retinal and Macular Surgery (17 papers). The work is most often cited by research in Ophthalmology (732 citations), Radiology, Nuclear Medicine and Imaging (416 citations) and Molecular Biology (365 citations). Matthias Lüke has collaborated with scholars based in Germany, Egypt and Netherlands. Frequent co-authors include Salvatore Grisanti, Julia Lüke, Khaled Nassar, Karl Ulrich Bartz‐Schmidt, Toni Schneider, Julia Beutel, Swaantje Grisanti, Christoph Lüke, Focke Ziemssen and Aysegül Tura. Their work appears in journals such as Clinical Cancer Research, Biophysical Journal and American Journal of Ophthalmology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.